MT-act is a CNRS spin-off. #techtransfer We develop class compounds to treat human pathologies that share a common molecular defect; dysfunction of the skeleton of the cells called microtubules - abbreviated MT. Stiffening of the skeleton of our cells is a central disease driver. That is why we act on them. We developed a technology platform to charter an entirely neglected pharmaceutical space. MT-act prioritizes indications based on scientific evidence, proven unmet medical needs and where the roadmap to patients is feasible and desired.
| Website | https://www.mt-act.com/ |
| Employees | 5 (5 on RocketReach) |
| Founded | 2019 |
| Address | CNRS, Montpellier, Occitanie 34000, FR |
| Technologies |
JavaScript
,
HTML
,
PHP
+15 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Drug Discovery, Cell Biology, Therapeutics, Biotechnology, Pharmaceutical Research, Tech Transfer, Scientific Research, Disease Treatment, Drug Development, Preclinical Research, Cellular Mechanisms, Biomedical Research, Innovative Therapies, Health Technology |
| Competitors | Control Solutions Group, Inc., Mechatronic Solutions, UE Precision Sensors Division (PSI), Precision Controls Company, Control Tech Group Limited, Dynamic Systems, Techtonic Engineering, Dynamic Control Technologies LLC, Motion Robotics Lda (view competitors) |
Looking for a particular MT-act employee's phone or email?
MT-act Questions
Khaled Hached is the COO of MT-act.
5 people are employed at MT-act.
MT-act is based in Montpellier, Occitanie.
Top MT-act Employees
Related Companies
